DOCS
Doximity, Inc.NYSEHealthcare$22.77-0.70%ClosedMarket Cap: $4.28B
As of 2026-04-06
Valuation
P/E (TTM)
17.87
PEG
0.95
P/B
4.36
P/S
6.71
EV/EBITDA
15.50
DCF Value
$23.36
FCF Yield
7.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
89.7%
Operating Margin
37.4%
Net Margin
37.5%
ROE
22.9%
ROA
23.1%
ROIC
20.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $185.1M | 89.9% | $71.9M | $61.6M | $0.31 | — |
| Q2 2026 | $168.5M | 90.3% | $63.7M | $62.1M | $0.31 | — |
| Q1 2026 | $145.9M | 89.2% | $54.5M | $53.3M | $0.27 | — |
| Q4 2025 | $138.3M | 89.5% | $48.7M | $62.5M | $0.31 | — |
| FY 2025 | $570.4M | 90.2% | $227.8M | $223.2M | $1.11 | — |
| Q3 2025 | $168.6M | 91.6% | $79.9M | $75.2M | $0.37 | — |
| Q2 2025 | $136.8M | 90.0% | $53.1M | $44.2M | $0.22 | — |
| Q1 2025 | $126.7M | 89.3% | $46.1M | $41.4M | $0.21 | — |
| Q4 2024 | $118.1M | 89.4% | $41.9M | $40.6M | $0.20 | — |
| FY 2024 | $475.4M | 89.3% | $163.9M | $147.6M | $0.72 | — |
| Q3 2024 | $135.3M | 91.0% | $58.6M | $48.0M | $0.24 | — |
| Q2 2024 | $113.6M | 88.8% | $33.8M | $30.6M | $0.15 | — |